These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 37802148)

  • 1. Alisol B 23-acetate broadly inhibits coronavirus through blocking virus entry and suppresses proinflammatory T cells responses for the treatment of COVID-19.
    Du Q; Liang R; Wu M; Yang M; Xie Y; Liu Q; Tang K; Lin X; Yuan S; Shen J
    J Adv Res; 2024 Aug; 62():273-290. PubMed ID: 37802148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of ACE2-Spike Interaction by an ACE2 Binder Suppresses SARS-CoV-2 Entry.
    Shin YH; Jeong K; Lee J; Lee HJ; Yim J; Kim J; Kim S; Park SB
    Angew Chem Int Ed Engl; 2022 Mar; 61(11):e202115695. PubMed ID: 35043545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and Evaluation of Entry Inhibitors for SARS-CoV-2 and Its Emerging Variants.
    Acharya A; Pandey K; Thurman M; Klug E; Trivedi J; Sharma K; Lorson CL; Singh K; Byrareddy SN
    J Virol; 2021 Nov; 95(24):e0143721. PubMed ID: 34550770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACE2-like carboxypeptidase B38-CAP protects from SARS-CoV-2-induced lung injury.
    Yamaguchi T; Hoshizaki M; Minato T; Nirasawa S; Asaka MN; Niiyama M; Imai M; Uda A; Chan JF; Takahashi S; An J; Saku A; Nukiwa R; Utsumi D; Kiso M; Yasuhara A; Poon VK; Chan CC; Fujino Y; Motoyama S; Nagata S; Penninger JM; Kamada H; Yuen KY; Kamitani W; Maeda K; Kawaoka Y; Yasutomi Y; Imai Y; Kuba K
    Nat Commun; 2021 Nov; 12(1):6791. PubMed ID: 34815389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
    Li K; Meyerholz DK; Bartlett JA; McCray PB
    mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide S4 is an entry inhibitor of SARS-CoV-2 infection.
    Liang Z; Wang J; Zhang H; Gao L; Xu J; Li P; Yang J; Fu X; Duan H; Liu J; Liu T; Ma W; Wu K
    Virology; 2024 Sep; 597():110149. PubMed ID: 38917689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition Mechanism of SARS-CoV-2 Infection by a Cholesterol Derivative, Nat-20(S)-yne.
    Murae M; Sakai S; Miyata N; Shimizu Y; Okemoto-Nakamura Y; Kishimoto T; Ogawa M; Tani H; Tanaka K; Noguchi K; Fukasawa M
    Biol Pharm Bull; 2024; 47(5):930-940. PubMed ID: 38692871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imatinib and methazolamide ameliorate COVID-19-induced metabolic complications via elevating ACE2 enzymatic activity and inhibiting viral entry.
    Li Z; Peng M; Chen P; Liu C; Hu A; Zhang Y; Peng J; Liu J; Li Y; Li W; Zhu W; Guan D; Zhang Y; Chen H; Li J; Fan D; Huang K; Lin F; Zhang Z; Guo Z; Luo H; He X; Zhu Y; Li L; Huang B; Cai W; Gu L; Lu Y; Deng K; Yan L; Chen S
    Cell Metab; 2022 Mar; 34(3):424-440.e7. PubMed ID: 35150639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-SARS-CoV-2 Viral Activity of Sweet Potato Trypsin Inhibitor via Downregulation of TMPRSS2 Activity and ACE2 Expression In Vitro and In Vivo.
    Jiang WP; Deng JS; Yu CC; Lin JG; Huang GJ
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-chain polyphosphates impair SARS-CoV-2 infection and replication.
    Ferrucci V; Kong DY; Asadzadeh F; Marrone L; Boccia A; Siciliano R; Criscuolo G; Anastasio C; Quarantelli F; Comegna M; Pisano I; Passariello M; Iacobucci I; Monica RD; Izzo B; Cerino P; Fusco G; Viscardi M; Brandi S; Pierri BM; Borriello G; Tiberio C; Atripaldi L; Bianchi M; Paolella G; Capoluongo E; Castaldo G; Chiariotti L; Monti M; De Lorenzo C; Yun KS; Pascarella S; Cheong JH; Kim HY; Zollo M
    Sci Signal; 2021 Jul; 14(690):. PubMed ID: 34230209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2-ACE2 Receptor Interactions.
    Day CJ; Bailly B; Guillon P; Dirr L; Jen FE; Spillings BL; Mak J; von Itzstein M; Haselhorst T; Jennings MP
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries.
    David AB; Diamant E; Dor E; Barnea A; Natan N; Levin L; Chapman S; Mimran LC; Epstein E; Zichel R; Torgeman A
    Molecules; 2021 May; 26(11):. PubMed ID: 34072087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of endosomal acidification suppress SARS-CoV-2 replication and relieve viral pneumonia in hACE2 transgenic mice.
    Shang C; Zhuang X; Zhang H; Li Y; Zhu Y; Lu J; Ge C; Cong J; Li T; Tian M; Jin N; Li X
    Virol J; 2021 Feb; 18(1):46. PubMed ID: 33639976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Repurposed ACE2 Inhibitors: SARS-CoV-2 Entry Blockers of Covid-19.
    Ahmad I; Pawara R; Surana S; Patel H
    Top Curr Chem (Cham); 2021 Oct; 379(6):40. PubMed ID: 34623536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Glucocorticoid and Androgen Receptor Modulator Reduces Viral Entry and Innate Immune Inflammatory Responses in the Syrian Hamster Model of SARS-CoV-2 Infection.
    Rocha SM; Fagre AC; Latham AS; Cummings JE; Aboellail TA; Reigan P; Aldaz DA; McDermott CP; Popichak KA; Kading RC; Schountz T; Theise ND; Slayden RA; Tjalkens RB
    Front Immunol; 2022; 13():811430. PubMed ID: 35250984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mRNA induced expression of human angiotensin-converting enzyme 2 in mice for the study of the adaptive immune response to severe acute respiratory syndrome coronavirus 2.
    Hassert M; Geerling E; Stone ET; Steffen TL; Feldman MS; Dickson AL; Class J; Richner JM; Brien JD; Pinto AK
    PLoS Pathog; 2020 Dec; 16(12):e1009163. PubMed ID: 33326500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humanized COVID-19 decoy antibody effectively blocks viral entry and prevents SARS-CoV-2 infection.
    Huang KY; Lin MS; Kuo TC; Chen CL; Lin CC; Chou YC; Chao TL; Pang YH; Kao HC; Huang RS; Lin S; Chang SY; Yang PC
    EMBO Mol Med; 2021 Jan; 13(1):e12828. PubMed ID: 33159417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel SARS-CoV-2 inhibition properties of the anti-cancer Kang Guan Recipe herbal formula.
    Wang WJ; Tang HT; Ou SC; Shen WJ; Chen CY; Li YC; Chang SY; Chang WC; Hsueh PR; Huang ST; Hung MC
    Cancer Lett; 2024 Nov; 604():217198. PubMed ID: 39197583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion of Host Cell Receptor into Virus Destructor by Immunodisc to Neutralize Diverse SARS-CoV-2 Variants.
    Hwang J; Kim BK; Moon S; Park W; Kim KW; Yoon JH; Oh H; Jung S; Park Y; Kim S; Kim M; Kim S; Jung Y; Park M; Kim JH; Jung ST; Kim SJ; Kim YS; Chung WJ; Song MS; Kweon DH
    Adv Healthc Mater; 2024 Jun; 13(14):e2302803. PubMed ID: 38329411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.